189 results on '"Krejcik, Zdenek"'
Search Results
2. Transcriptomic alterations in the olfactory bulb induced by exposure to air pollution: Identification of potential biomarkers and insights into olfactory system function
3. RUNX1 mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS
4. Dysregulation of transposable elements and PIWI-interacting RNAs in myelodysplastic neoplasms.
5. Transcriptomic and epigenomic profiling reveals altered responses to diesel emissions in Alzheimer's disease both in vitro and in population‐based data.
6. Detecting attomolar concentrations of microRNA related to myelodysplastic syndromes in blood plasma using a novel sandwich assay with nanoparticle release
7. Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower‐risk myelodysplastic neoplasms
8. Transcriptome changes in humans acutely exposed to nanoparticles during grinding of dental nanocomposites.
9. Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1
10. Interaction-Based Aggregation of mRNA and miRNA Expression Profiles to Differentiate Myelodysplastic Syndrome
11. Molecular Patterns Discriminate Accommodation and Subclinical Antibody-mediated Rejection in Kidney Transplantation
12. Molecular diagnostics identifies risks for graft dysfunction despite borderline histologic changes
13. Rapid and sensitive detection of multiple microRNAs in cell lysate by low-fouling surface plasmon resonance biosensor
14. Network-constrained forest for regularized classification of omics data
15. Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosis
16. Differential Expression of Metallothioneins and Slc Family Genes in Accommodation and Subclinical Antibody Mediated Rejection
17. Isolated V-Lesion Early after Kidney Transplantation May Not Truly Represent a Rejection
18. Aging-Related Gene Expression Signatures Define Likelihood of Disease Progression in Patients with Lower-Risk Myelodysplastic Syndromes
19. Changes of Transcriptomic Landscape in Blasts of Responding and Refractory Acute Myeloid Leukemia Patients after Chemotherapy
20. Upregulation of ZEB1-Derived Circular RNAs Is Associated with SF3B1-Mutated Myelodysplastic Neoplasms
21. Changes Associated With Lenalidomide Treatment in the Gene Expression Profiles of Patients With Del(5q)
22. Deregulation of Gene Expression Induced by Environmental Tobacco Smoke Exposure in Pregnancy
23. Biometal Dyshomeostasis in Olfactory Mucosa of Alzheimer's Disease Patients
24. Noncoding RNAs and Their Response Predictive Value in Azacitidine-treated Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-related Changes
25. Transposable elements and Piwi‑interacting RNAs in hemato‑oncology with a focus on myelodysplastic syndrome (Review)
26. Circular RNAs in Myelodysplastic Syndromes and Impact of SF3B1 Mutations on Their Expression
27. Isethionate formation from taurine in Chromohalobacter salexigens: purification of sulfoacetaldehyde reductase
28. Different Mutations in SF3B1 Gene Have Specific Transcriptomic Characteristics in Myelodysplastic Neoplasms
29. Accelerated Progression in Lower-Risk Myelodysplastic Neoplasms: Attenuated Cell Cycle, DNA Damage Response, and Augmented Oncogenic Transcriptome Signatures
30. Low Plasma Citrate Levels and Specific Transcriptional Signatures Associated with Quiescence of CD34+ Progenitors Predict Azacitidine Therapy Failure in MDS/AML Patients
31. LncRNA Profiling Reveals That the Deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 Is Associated with Higher-Risk Myelodysplastic Syndrome
32. Circular RNAs in Hematopoiesis with a Focus on Acute Myeloid Leukemia and Myelodysplastic Syndrome
33. Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome
34. Molecular Fingerprints of Borderline Changes in Kidney Allografts Are Influenced by Donor Category
35. Peritoneal dialysis induces alterations in the transcriptome of peritoneal cells before detectible peritoneal functional changes
36. Circulating Small Noncoding RNAs As Novel Semi-Invasive Markers of Patient Survival in Myelodysplastic Syndromes
37. RUNX1mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS
38. Relationship between Altered Gene Expression and DNA Methylation of the DLK1-DIO3 region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Myelodysplasia-Related Changes
39. Deregulated Expression of Long Noncoding RNAs H19, LEF1-AS1, TCL6, and WT1-AS1 Predicts Poor Outcome of Patients with Myelodysplastic Syndromes
40. Early isolated V-lesion may not truly represent rejection of the kidney allograft
41. Relationship between Altered miRNA Expression and DNA Methylation of the DLK1-DIO3 Region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Myelodysplasia-Related Changes
42. Comparison of genomic profiles to reveal heterogenous patterns of tumor evolution in primary and recurrent diffuse gliomas.
43. MicroRNA profiles as predictive markers of response to azacitidine therapy in myelodysplastic syndromes and acute myeloid leukemia
44. FP482ACTIVITY OF B CELL RELATED TRANSCRIPT PROVOKED BY PERITONEAL DIALYSIS TREATMENT IS NOT ACCOMPANIED BY B CELL RELEASE IN PERITONEAL EFFLUENT
45. FP696ISOLATED V-LESION EARLY AFTER KIDNEY TRANSPLANTATION MAY NOT TRULY REPRESENT A REJECTION
46. Aberrant expression of the microRNA cluster in 14q32 is associated with del(5q) myelodysplastic syndrome and lenalidomide treatment
47. SP494TRANSCRIPTOME ALTERATIONS DURING PERITONEAL DIALYSIS TREATMENT
48. Peritoneal dialysis induces alterations in the transcriptome of peritoneal cells before detectible peritoneal functional changes.
49. Recurrent chromosomal breakpoints in patients with myelodysplastic syndromes and complex karyotype versus fragile sites
50. Primary and recurrent diffuse astrocytomas: genomic profile comparison reveals acquisition of biologically relevant aberrations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.